Published in Am J Kidney Dis on June 01, 2006
Al amyloidosis. Orphanet J Rare Dis (2012) 1.29
Renal amyloidosis in children. Pediatr Nephrol (2011) 0.96
The amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J (2012) 0.82
Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases. Korean J Lab Med (2011) 0.79
AL Amyloidosis Complicated by Persistent Oral Bleeding. Case Rep Hematol (2015) 0.75
Acute cardiac tamponade in light-chain amyloidosis. BMJ Case Rep (2014) 0.75
Amyloidosis and Anesthesia. Anesth Essays Res (2017) 0.75
Primary systemic amyloidosis as a real diagnostic challenge - case study. Cent Eur J Immunol (2014) 0.75
Curious case of raccoon eye under general anaesthesia. Indian J Anaesth (2016) 0.75
A man with new onset of ascites and edema. Medscape J Med (2008) 0.75
Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant (2010) 2.35
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis (2002) 1.62
Biocompatibility of a bicarbonate/lactate-buffered PD fluid tested with a double-chamber cell culture system. Perit Dial Int (2005) 1.39
A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int (2008) 1.24
Surgical treatment of renal artery dissection in 25 patients: indications and results. J Vasc Surg (2003) 1.11
Management of arterial stenosis affecting kidney graft perfusion: a single-centre study in 53 patients. Am J Transplant (2005) 1.09
Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology (2002) 1.01
Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost (2007) 0.97
Kidney transplantation from related and unrelated living donors in a single German centre. Nephrol Dial Transplant (2003) 0.96
Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis (2006) 0.93
Iliac artery stenosis proximal to a kidney transplant: clinical findings, duplex-sonographic criteria, treatment, and outcome. Transplantation (2003) 0.93
Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol (2002) 0.92
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis (2004) 0.90
Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transpl Int (2002) 0.90
Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. Nephron Exp Nephrol (2003) 0.89
Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity. Nephrol Dial Transplant (2002) 0.87
Opportunistic infections after renal transplantation. Curr Opin Urol (2002) 0.85
Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol (2006) 0.84
Severe serum sickness following pneumococcal vaccination in an AIDS patient. Int J STD AIDS (2006) 0.84
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol Dial Transplant (2009) 0.84
Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Nephrol Dial Transplant (2004) 0.83
Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int (2004) 0.83
Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study. Nephrol Dial Transplant (2007) 0.81
Value of diabetes as an independent predictor of death in subjects with end-stage renal disease. Med Klin (Munich) (2006) 0.81
Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge. Am J Kidney Dis (2002) 0.81
Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: relation to peritoneal transport. Am J Kidney Dis (2004) 0.81
Tandem plasmapheresis and haemodialysis as a safe procedure in 82 patients with immune-mediated disease. Nephrol Dial Transplant (2008) 0.80
Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant (2004) 0.79
Indicators of acute and persistent renal damage in adult thrombotic microangiopathy. PLoS One (2012) 0.79
Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin Transplant (2007) 0.79
Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes. Nephron (2002) 0.79
Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res (2003) 0.78
Influence of cytokine gene polymorphisms on IgA nephropathy. Ren Fail (2008) 0.78
Influence of beta3 integrin gene Leu/Pro33 polymorphism on primary glomerulonephritis. Nephron Exp Nephrol (2004) 0.78
The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study. Clin Appl Thromb Hemost (2009) 0.78
Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients. Nephrol Dial Transplant (2012) 0.78
Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II. Transpl Int (2008) 0.78
Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells. Nephrol Dial Transplant (2008) 0.78
Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat. Nephron Exp Nephrol (2005) 0.77
Kidney transplantation in the elderly: age-matching as compared to HLA-matching: a single center experience. Transplantation (2002) 0.77
Post-transplant distal limb syndrome: clinical diagnosis and long-term outcome in 37 renal transplant recipients. Transpl Int (2008) 0.77
Duplex ultrasound and renin ratio predict treatment failure after revascularization for renal artery stenosis. Am J Hypertens (2006) 0.77
Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med (2003) 0.77
Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. J Nephrol (2008) 0.77
Functional von Willebrand Factor assays are not predictive for the absence of highest-molecular weight von Willebrand Factor multimers in patients with aortic-valve stenosis. Thromb Haemost (2005) 0.77
Highly efficient lentiviral transduction of phenotypically and genotypically characterized endothelial progenitor cells from adult peripheral blood. Blood Coagul Fibrinolysis (2010) 0.76
Influence of cytokine gene polymorphisms on focal segmental glomerulosclerosis. Am J Nephrol (2004) 0.76
Cerivastatin inhibits proliferation of interleukin-1 beta-induced rat mesangial cells by enhanced formation of nitric oxide. Eur J Pharmacol (2004) 0.76
Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice. Blood Coagul Fibrinolysis (2015) 0.75
The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies. Clin Appl Thromb Hemost (2009) 0.75
Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient. Am J Kidney Dis (2006) 0.75
[Diagnosis, treatment, and prognosis of renal artery stenosis]. Med Klin (Munich) (2006) 0.75
Effects of candesartan on glomerular hemodynamics and permselectivity in patients with favorable renal allograft function. Transplantation (2005) 0.75
No evidence for an association of AB0 blood group and manifestation of thrombotic microangiopathies. Int J Cardiol (2011) 0.75
Acute pain over the kidney graft and Duplex-sonographic findings mimicking complete renal transplant vein thrombosis. Nephrol Dial Transplant (2002) 0.75
[Arteriosclerotic renal artery stenosis. Significance, diagnosis and therapy options]. Med Klin (Munich) (2002) 0.75
High clotting factor activities and enhanced platelet-related haemostasis in a patient with recurrent episodes of thrombotic-thrombocytopenic purpura: additional risk factors for onset and recurrence? Nephrol Dial Transplant (2005) 0.75
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery. Clin Appl Thromb Hemost (2007) 0.75
No evidence for involvement of prothrombotic platelet receptor polymorphisms in acute coronary stent thrombosis. Int J Cardiol (2007) 0.75
The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies. Clin Appl Thromb Hemost (2007) 0.75
Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies? Clin Appl Thromb Hemost (2008) 0.75